Evidence map›Paper›PMID 35201760›Full record

ArticleACS applied bio materials2022

Folic Acid-Adorned Curcumin-Loaded Iron Oxide Nanoparticles for Cervical Cancer.

Marzieh Ramezani Farani, Maryam Azarian, Hamid Heydari Sheikh Hossein, Zohreh Abdolvahabi, Zahra Mohammadi Abgarmi, Arash Moradi, Seyyedeh Maedeh Mousavi, Milad Ashrafizadeh, Pooyan Makvandi, Mohammad Reza Saeb and 1 more

Erratum issuedAbstract read
In one paragraph

Article in ACS applied bio materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Magnetic nanoparticles as promising materials for the future of medicine.Journal of materials science. Materials in medicine · 2026
    Review
  3. Article
  4. Design and characterization of SrONaunyn-Schmiedeberg's archives of pharmacology · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Curcumin in treatment of hematological cancers: Promises and challenges.Journal of traditional and complementary medicine · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Marzieh Ramezani FaraniToxicology and Diseases Group (TDG), Pharmaceutical Sciences Research Center (PSRC), The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, 1417614411 Tehran, Iran.
Maryam AzarianDepartment of Radiology, Charité - Universitätsmedizin Berlin, Charitéplatz 1, Berlin 10117, Germany.
Hamid Heydari Sheikh HosseinDepartment of Biotechnology, Faculty of Biological Sciences and Technology, University of Isfahan, Isfahan 81746-73441, Iran.
Zohreh AbdolvahabiMetabolic Diseases Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin 241567, Iran.
Zahra Mohammadi AbgarmiDepartment of Clinical Biochemistry, Faculty of Medical Science, Tarbiat Modares University, Tehran 1668814811, P.O. Box: 14115-331, Iran.
Arash MoradiDepartment of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran 1668814811, P.O. Box: 14956-161, Iran.
Seyyedeh Maedeh MousaviSchool of Medicine, Bam University of Medical Sciences, Bam 7661771967, Iran.
Milad AshrafizadehFaculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanlı, Tuzla, Istanbul 34956, Turkey.
Pooyan MakvandiIstituto Italiano di Tecnologia, Centre for Materials Interfaces, viale Rinaldo Piaggio 34, 56025 Pontedera, Pisa, Italy.ORCID 0000-0003-2456-0961
Mohammad Reza SaebDepartment of Polymer Technology, Faculty of Chemistry, Gdańsk University of Technology, G. Narutowicza 11/12 80-233, Gdańsk, 80-233, Poland.ORCID 0000-0001-7860-5243
Navid RabieeDepartment of Physics, Sharif University of Technology, P.O. Box 11155-9161, Tehran, Iran.ORCID 0000-0002-6945-8541

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a deadly disease that has long plagued humans and has become more prevalent in recent years. The common treatment modalities for this disease have always faced many problems and complications, and this has led to the discovery of strategies for cancer diagnosis and treatment. The use of magnetic nanoparticles in the past two decades has had a significant impact on this. One of the objectives of the present study is to introduce the special properties of these nanoparticles and how they are structured to load and transport drugs to tumors. In this study, iron oxide (Fe

Indexed as

CurcuminUterine Cervical NeoplasmsAnimalsFemaleFolic AcidHeLa CellsHumansMagnetic Iron Oxide NanoparticlesMiceCurcuminFolic Acidcervical cancer therapycurcuminiron oxide nanoparticlesMRIpolyglyceroltargeted delivery

Identifiers

PMID35201760
PMCPMC8941513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.